Quarterly report pursuant to Section 13 or 15(d)

CONSOLIDATED BALANCE SHEETS

v3.24.3
CONSOLIDATED BALANCE SHEETS - USD ($)
$ in Thousands
Sep. 28, 2024
Dec. 30, 2023
Current assets:    
Cash and cash equivalents $ 38,105 $ 50,951
Accounts receivable, net 8,427 7,365
Inventory, net 97,235 128,901
Other current assets 6,477 6,121
Total current assets 150,244 193,338
Property and equipment, net 34,494 26,389
Right-of-use - assets - operating leases, net 28,029 19,542
Right-of-use - assets - finance leases, net 11,808 15,255
Other non-current assets 3,064 3,331
Total assets 227,639 257,855
Current liabilities:    
Accounts payable 59,715 77,851
Accrued expenses 19,020 20,770
Right-of-use - obligation - operating, current 5,668 4,749
Right-of-use - obligation - finance, current 3,655 4,308
Other current liabilities 4,843 5,308
Total current liabilities 92,901 112,986
Right-of-use - obligation - operating, non-current 24,797 16,742
Right-of-use - obligation - finance, non-current 9,680 12,327
Other non-current liabilities 3,062 2,969
Total liabilities 130,440 145,024
Commitments and contingencies
Stockholders' equity:    
Common stock, $0.001 par value; 100,000 shares authorized; 57,386 and 56,303 shares issued and outstanding as of September 28, 2024 and December 30, 2023 (of which 3,786 are treasury stock) 61 60
Treasury stock (11,912) (11,912)
Additional paid-in capital 322,337 312,874
Accumulated other comprehensive income 870 783
Accumulated deficit (214,157) (188,974)
Total stockholders' equity 97,199 112,831
Total liabilities and stockholders' equity $ 227,639 $ 257,855